Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06991413Not ApplicableCompleted

Impact of an App on the Quality of Life and Symptoms in Individuals With Premenstrual Syndrome

Role: lead

NCT06987617Not ApplicableCompleted

Pilot Study to Investigate the Impact of an App on the Quality of Life and Symptoms of Individuals Affected by Menopause

Role: lead

NCT06912594Not ApplicableNot Yet Recruiting

App Impact on Quality of Life and Symptoms in PCOS

Role: lead

NCT06283225Not ApplicableNot Yet Recruiting

Pilot Study to Investigate the Effect of a Dysmenorrhoea App

Role: lead

NCT04883073Not ApplicableCompleted

Impact on Quality of Life of "Endo-App" (ELEA)

Role: collaborator

All 5 trials loaded